NYSE:GCOGenesco Stock Price, Forecast & News

Genesco's stock was trading at $24.11 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, GCO shares have decreased by 31.9% and is now trading at $16.42.
View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesco in the last year. There are currently 1 hold rating and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Genesco.

Genesco is scheduled to release its next quarterly earnings announcement on Friday, September 4th 2020.
View our earnings forecast for Genesco.

Genesco Inc. (NYSE:GCO) released its earnings results on Tuesday, June, 9th. The company reported ($3.65) earnings per share for the quarter, missing analysts' consensus estimates of ($2.52) by $1.13. The company earned $279.20 million during the quarter, compared to the consensus estimate of $306.47 million. Genesco had a positive return on equity of 2.57% and a negative net margin of 4.03%. Genesco's quarterly revenue was down 43.7% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.36 earnings per share.
View Genesco's earnings history.

Genesco declared that its Board of Directors has authorized a stock buyback plan on Friday, May 3rd 2019, which allows the company to buyback $100,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 11.7% of its shares through open market purchases. Shares buyback plans are usually an indication that the company's management believes its shares are undervalued.

4 Wall Street analysts have issued 12 month price targets for Genesco's shares. Their forecasts range from $26.00 to $53.00. On average, they anticipate Genesco's stock price to reach $35.75 in the next twelve months. This suggests a possible upside of 117.7% from the stock's current price.
View analysts' price targets for Genesco.

Media headlines about GCO stock have trended neutral recently, InfoTrie Sentiment Analysis reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Genesco earned a news sentiment score of 0.2 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days.
View the latest news about Genesco.

Genesco saw a increase in short interest in the month of July. As of July 15th, there was short interest totaling 2,120,000 shares, an increase of 11.0% from the June 30th total of 1,910,000 shares. Based on an average trading volume of 386,400 shares, the days-to-cover ratio is presently 5.5 days. Currently, 15.4% of the shares of the company are short sold.
View Genesco's Current Options Chain.

Some companies that are related to Genesco include TJX Companies (TJX), Ross Stores (ROST), GAP (GPS), Foot Locker (FL), Urban Outfitters (URBN), American Eagle Outfitters (AEO), Guess? (GES), Buckle (BKE), Abercrombie & Fitch (ANF), Zumiez (ZUMZ), Designer Brands (DBI), Childrens Place (PLCE), Shoe Carnival (SCVL), Caleres (CAL) and Citi Trends (CTRN).
View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Genesco investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intelsat (I), Bank of America (BAC), Micron Technology (MU), Transocean (RIG), NIC (EGOV) and AMC Entertainment (AMC).

Genesco trades on the New York Stock Exchange (NYSE) under the ticker symbol "GCO."

Genesco's stock is owned by a number of institutional and retail investors. Top institutional investors include LSV Asset Management (3.54%), Smith Graham & Co. Investment Advisors LP (1.27%), Foundry Partners LLC (1.18%), Principal Financial Group Inc. (0.71%), Robeco Institutional Asset Management B.V. (0.64%) and SG Americas Securities LLC (0.55%). Company insiders that own Genesco stock include Daniel E Ewoldsen, Kathleen Mason, Mario Gallione, Marty G Dickens, Robert J Dennis and Thurgood Marshall Jr.
View institutional ownership trends for Genesco.

GCO stock was sold by a variety of institutional investors in the last quarter, including Robeco Institutional Asset Management B.V., LSV Asset Management, Principal Financial Group Inc., Nisa Investment Advisors LLC, New York State Teachers Retirement System, Pacer Advisors Inc., and Texas Permanent School Fund. Company insiders that have sold Genesco company stock in the last year include Daniel E Ewoldsen, and Kathleen Mason.
View insider buying and selling activity for Genesco.

GCO stock was bought by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Foundry Partners LLC, UBS Group AG, Exchange Traded Concepts LLC, Wedge Capital Management L L P NC, Smith Graham & Co. Investment Advisors LP, Pinnacle Financial Partners Inc., and Cahaba Wealth Management Inc..
View insider buying and selling activity for Genesco.

Shares of GCO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of GCO stock can currently be purchased for approximately $16.42.

Genesco has a market capitalization of $241.08 million and generates $2.20 billion in revenue each year. The company earns $61.38 million in net income (profit) each year or $4.58 on an earnings per share basis. Genesco employs 22,050 workers across the globe.

The official website for Genesco is www.genesco.com.

Genesco's mailing address is Genesco Park 1415 Murfreesboro Pike, NASHVILLE TN, 37217. The company can be reached via phone at 615-367-7000 or via email at [email protected]